Mineralys Therapeutics, Inc. (MLYS)
28.99
+2.34
(+8.78%)
USD |
NASDAQ |
May 01, 11:59
Mineralys Therapeutics Market Cap : 2.390B for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 27.84B |
| Syndax Pharmaceuticals, Inc. | 1.760B |
| Regeneron Pharmaceuticals, Inc. | 73.98B |
| Immunic, Inc. | 127.91M |
| Cogent Biosciences, Inc. | 6.215B |
Market Cap Related Metrics
| Price to Book Value | 3.696 |
| Price | 28.99 |
| Earnings Yield | -8.20% |